Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / RGEN - Repligen and Navigo develop molecule for purification of COVID-19 vaccines


RGEN - Repligen and Navigo develop molecule for purification of COVID-19 vaccines

Repligen (RGEN) and Navigo Proteins GmbH have developed a novel affinity ligand targeting the spike protein that can be used to purify COVID-19 vaccines.The companies are scaling up manufacturing and developing the related affinity chromatography resin (high purity capture of the molecule).The final resin product should be commercially available in Q1 2021.

For further details see:

Repligen and Navigo develop molecule for purification of COVID-19 vaccines
Stock Information

Company Name: Repligen Corporation
Stock Symbol: RGEN
Market: NASDAQ
Website: repligen.com

Menu

RGEN RGEN Quote RGEN Short RGEN News RGEN Articles RGEN Message Board
Get RGEN Alerts

News, Short Squeeze, Breakout and More Instantly...